(Q40362524)

English

Successful treatment of daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus bacteremia with the addition of rifampin to daptomycin

scientific article published on 30 March 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Successful treatment of daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus bacteremia with the addition of rifampin to daptomycin (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

methicillin-resistant Staphylococcus aureus

0 references

1 reference

based on heuristic

inferred from title

Staphylococcus aureus

1 reference

based on heuristic

inferred from title

author name string

Nasir M Ahmad

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Albert D Rojtman

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

language of work or name

0 references

publication date

30 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Annals of Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

44

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

918-921

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M665

21 January 2018

Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M665

21 January 2018

Daptomycin nonsusceptibility in Staphylococcus aureus with reduced vancomycin susceptibility is independent of alterations in MprF.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M665

21 January 2018

Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M665

21 January 2018

Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M665

21 January 2018

Vancomycin heteroresistance and methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M665

21 January 2018

Rapid bactericidal activity of daptomycin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus peritonitis in mice as measured with bioluminescent bacteria

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M665

21 January 2018

Comparative bactericidal activities of daptomycin and vancomycin against glycopeptide-intermediate Staphylococcus aureus (GISA) and heterogeneous GISA isolates

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M665

21 January 2018

Perspectives on Daptomycin resistance, with emphasis on resistance in Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M665

21 January 2018

Analysis of cell membrane characteristics of in vitro-selected daptomycin-resistant strains of methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M665

21 January 2018

Adjunctive use of rifampin for the treatment of Staphylococcus aureus infections: a systematic review of the literature

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M665

21 January 2018

Use of intravenous rifampin in neonates with persistent staphylococcal bacteremia

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M665

21 January 2018

Antimicrobial activities of daptomycin, vancomycin, and oxacillin in human monocytes and of daptomycin in combination with gentamicin and/or rifampin in human monocytes and in broth against Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M665

21 January 2018

Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M665

21 January 2018

Efficacy of Daptomycin in Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M665

21 January 2018

Effects of daptomycin in combination with other antimicrobial agents: a review of in vitro and animal model studies

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M665

21 January 2018

Daptomycin-rifampin for a recurrent MRSA joint infection unresponsive to vancomycin-based therapy

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M665

21 January 2018

Addition of rifampin to standard therapy for treatment of native valve infective endocarditis caused by Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M665

21 January 2018

Identifiers

10.1345/APH.1M665

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40362524&oldid=2170343526"